Both Losing Weight RX and Mochi Health offer compounded GLP-1 medications specifically compounded semaglutide and compounded tirzepatide
The GLP-1 drug Wegovy for weight issues or obesity is approved for individuals with a BMI of 26-plus and co-morbidities, or those with a BMI of 30-plus
The need of the hour is to have more randomized, double-blind, placebo-controlled trials with a larger sample size, long term follow-up period, with well defined primary and secondary outcomes, targeted to evaluate the efficacy and safety of the skin-lightening effects of topical, oral and parenteral glutathione
In studies exploring protein haptenation by amoxicillin, we observed that reducing agents influenced the extent of amoxicillin-protein adducts formation
Pegylation extends half-life from 2 hours (native IGF-1 Ec) to 24+ hours, reducing injection frequency while maintaining safety profile similar to parent peptide